XBiotech Inc.
XBIT
$2.20
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -20.41% | -75.71% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.04% | -78.91% | |||
| Operating Income | 2.04% | 78.91% | |||
| Income Before Tax | -22.47% | 79.65% | |||
| Income Tax Expenses | -6.12% | -35.53% | |||
| Earnings from Continuing Operations | -22.22% | 79.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -22.22% | 79.53% | |||
| EBIT | 2.04% | 78.91% | |||
| EBITDA | 1.65% | 79.77% | |||
| EPS Basic | -22.20% | 79.53% | |||
| Normalized Basic EPS | -22.54% | 80.08% | |||
| EPS Diluted | -22.20% | 79.53% | |||
| Normalized Diluted EPS | -22.54% | 80.08% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||